HCC manifested a global reprogramming of glutamine transporters compared to normal liver: SLC38A3 levels decreased, whereas SLC38A1, SLC7A6, and SLC1A5 levels increased. This evidence concerns the gene SLC1A5 and hepatocellular carcinoma.